在癌症中对FGFR1的药理和生物向
Shuai Fan1, Yuxin Chen1, Wenyu Wang1
1State Key Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
纤维细胞生长因子受体1 (FGFR1) 的改变通过激活关键细胞信号通路来驱动癌症. 本综述详细介绍了FGFR1异常和当前针对性疗法,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 纤维细胞生长因子受体1 (FGFR1) 对细胞增殖,分化和生存至关重要.
- 包括RAS-MAPK和PI3K-AKT在内的FGFR1信号通路对于正常的细胞功能至关重要.
- 异常的FGFR1信号驱动通过不受控制的细胞分裂和转移导致瘤发生.
研究的目的:
- 审查FGFR1激活机制和信号通路.
- 详细说明癌症中FGFR1异常的类型.
- 提供针对FGFR1变化的当前治疗方法的概述.
主要方法:
- 关于FGFR1激活,信号和异常的文献综述.
- 目前针对FGFR的治疗策略的汇编1.
主要成果:
- FGFR1的改变导致构成性通路的激活,促进癌症.
- 各种FGFR1异常有助于瘤发生.
- 针对特定的FGFR1变异,有针对性的疗法正在出现.
结论:
- 了解FGFR1异常是开发有效癌症治疗的关键.
- 针对特定的FGFR1变异提供了新的治疗前景.
- 对FGFR1向药物的进一步研究可以改善患者的治疗结果.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
